Liraglutide, sold under the brand name Victoza among others, is an anti-diabetic medication used to treat type 2 diabetes, and chronic obesity.
Patients with type 2 diabetes who were at high risk for cardiovascular disease were randomly assigned, in a 1:1 ratio, to receive liraglutide or placebo.
Results: The impact of liraglutide on cardiovascular outcomes was examined in a large welldesigned study published in 2016, the LEADER trial. This study included 9,340 patients with advanced type 2 diabetes and high baseline cardiovascular risk.
Before using Victoza, tell your health care provider if you: 1. have or have had problems with your pancreas, kidneys, or liver 2. have any other medical conditions or severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food 3. are scheduled to have surgery or other procedures that ... See full list on victoza.com See full list on victoza.com Victozamay cause serious side effects, including: 1. inflammation of your pancreas (pancreatitis). Stop using Victozaand call your health care provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back 2. low blood sugar (hypoglyc... See full list on victoza.com Liraglutide is also recommended in patients with T2D and cardiovascular disease, or very high/high cardiovascular risk, to reduce cardiovascular events and the risk of death (20). Cardiovascular outcomes trials have established cardiovascular safety of GLP-1 receptor agonists; some agents within this class (eg, liraglutide, semaglutide, dulaglutide, and tirzepatide) reduce the risk of major adverse cardiovascular events in people with type 2 diabetes, or in those with obesity with atherosclerotic cardiovascular disease ... Effects of liraglutide (vs. placebo) on CV outcomes among patients with and without baseline metformin use, adjusted for baseline covariates with inverse probability weighting. Although absolute event numbers are small and not always statistically significant, liraglutide (Victoza) is consistently the best second drug to prevent cardiovascular events in patients with...
Liraglutide is also recommended in patients with T2D and cardiovascular disease, or very high/high cardiovascular risk, to reduce cardiovascular events and the risk of death (20).
Such details provide a deeper understanding and appreciation for Liraglutide Cardiovascular Medication.
Effects of liraglutide (vs. placebo) on CV outcomes among patients with and without baseline metformin use, adjusted for baseline covariates with inverse probability weighting.
Although absolute event numbers are small and not always statistically significant, liraglutide (Victoza) is consistently the best second drug to prevent cardiovascular events in patients with...
Find patient medical information for Liraglutide (Victoza) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings.
